Latest News about Psychedelics Research
Recent news which mentions Psychedelics Research
Can LSD Therapy Calm Anxious Dogs? First-Of-Its-Kind Study Uncovers New Possibilities
September 27, 2024
Tickers
DOGS
PETS
Tags
LSD Therapy
veterinary
Market News
From
Benzinga
Psilocybin Breakthrough: Study Reveals Potential Application For Body Dysmorphic Disorder
September 26, 2024
Tickers
CMPS
NEWS
Tags
Compass Pathways
Psilocybin
Market News
From
Benzinga
Non-Hallucinogenic Psychedelic Treatment For Anxiety And Depression In Pre-Clinical Models: Enveric Biosciences' Breakthrough Research
September 25, 2024
Tickers
CCC
ENVB
NEWS
Tags
News
Health Care
ENVB
From
Benzinga
DEA Boosts Psychedelics Production For Research, Cannabis Quotas Hold Steady Ahead Of Rescheduling
September 24, 2024
Tickers
NEWS
Tags
Cannabis
Market News
Psilocybin
From
Benzinga
Fed Health Agency Funds $2.4M Study On Psychedelics Treatment For Meth Addiction
August 28, 2024
Tickers
NEWS
Tags
methamphetamine
Market News
Cannabis
From
Benzinga
Podcast - Intro To A Toll-Free Psychedelics Information Line, An Educational Tool By Unlimited Sciences
April 29, 2024
Tickers
NEWS
Tags
News
Psychology
Unlimited Sciences
From
Benzinga
Psychedelics Headlines: Dementia Prevention, Psychological Flexibility, Ancient Romans' Trips And More
April 17, 2024
Tickers
AWKNF
BETRF
CMND
FLHLF
Tags
FLHLF
TRUFF
Cannabis
From
Benzinga
Psyched: DEA Revisits Ban On Two Psychedelics, Farewell Russell Newcombe, Podcast Episode On Kanna & More
April 17, 2024
Tickers
AGNPF
ATAI
CMND
CMPS
Tags
Psychedelics
Psychedelics Research
IXHL
From
Benzinga
Numinus Wellness Q2 2024 Revenue Declines Amid Clinic Reshuffling And Expected Industry Trends
April 15, 2024
Tickers
NEWS
NUMIF
Tags
News
financial results
Earnings
From
Benzinga
Optimi To Supply Psilocybin For New Zealand's Mātai Medical Research Institute
April 09, 2024
Tickers
NEWS
OPTHF
Tags
Psychedelics
Benzinga
Psilocybin program
From
Benzinga
Psychedelics Reform Update: Missouri's $10M Budget, Maine's & Maryland's Study Groups, Oregon's Re-Crim And More
April 05, 2024
Tags
Global
Cannabis
Market News
From
Benzinga
DMT For Stroke Treatment: Algernon Sets Phase 2 Clinical Trial Design
April 03, 2024
Tickers
AGNPF
Tags
AGNPF
Management
Market News
From
Benzinga
Psychedelics Headlines: A Form Of Life, Treating Chronic Pain, Microdosing And More
March 30, 2024
Tickers
CMND
CMPS
CYBN
FLHLF
Tags
Psychedelics Research
CYBN
MDXXF
From
Benzinga
Psyched: 5-MeO-DMT For Depression, Utah Hospitals Providing Therapy, Elon Musk And Meta's Influence
March 29, 2024
Tickers
ATAI
CMND
CMPS
DRUG
Tags
GHRS
SILO
ATAI
From
Benzinga
Atai Life Sciences Q4 And Full-Year 2023 Results: Steep Cash Drain Yet 2026 Target Remains, Update On Psychedelic Pipeline
March 29, 2024
Tickers
ATAI
CMPS
Tags
Cannabis
Market News
Earnings
From
Benzinga
Intranasal 5-MeO-DMT Clinical Trial Offers Hope For Treatment-Resistant Depression
March 28, 2024
Tickers
ATAI
NEWS
Tags
Market News
Cannabis
treatment/resistant depression
From
Benzinga
PharmAla's Novel MDMA Mixture Awarded US Patent, Enabling IP Protection And Further Development
March 27, 2024
Tickers
MDXXF
Tags
MDMA treatment
Biotech
Benzinga
From
Benzinga
Two Top Biotechs Forge MDMA Supply Deals For Clinical Research
March 26, 2024
Tickers
MDXXF
NEWS
NUMIF
OPTHF
Tags
Biotech
Psychedelics
Tel Aviv University
From
Benzinga
Utah Hospitals Will Soon Provide Psilocybin And MDMA Therapy For Mental Health Conditions
March 25, 2024
Tickers
NEWS
NUMIF
Tags
Cannabis
Market News
News
From
Benzinga
Congress Discusses Remaining FY2024 Spending Bill With Provisions On Cannabis Sales And Psychedelic Clinical Trials
March 22, 2024
Tags
Psychedelics
Benzinga
B/C/ cannabis
From
Benzinga
Psyched: LSD, Psilocybin As Breakthrough Therapies, $14M Fed Grant For Ibogaine, Indiana's Research And More
March 20, 2024
Tickers
ATAI
CMND
CMPS
CYBN
Tags
Psychedelics Reform
DRUG
MNMD
From
Benzinga
Psychedelics Headlines: Substitution Survey, Frank Herbert's Magic Mushrooms, Celestial Plans And News Review
March 16, 2024
Tickers
ATAI
BETRF
CMND
ENVB
Tags
ATAI
NUMIF
ENVB
From
Benzinga
Psyched: New Evidence Shows Psilocybin As Anxiety Therapy, Open-Source Learning For Therapists, Enveric's Licensing Deals And More
March 04, 2024
Tickers
ATAI
CMND
CMPS
CYBN
Tags
Management
Financing
DRUG
From
Benzinga
Psychedelics Headlines: Predicting Readiness, Correcting The Hype, Good And Bad Drugs, Training Programs And More
March 01, 2024
Tickers
BRAXF
FLHLF
OPTHF
SILFF
Tags
BRAXF
Events
SILFF
From
Benzinga
Beckley Academy's Open-Source Psychedelic Therapy Learning Framework Is Out: What's It All About? Authoring Team Shares Insights
February 29, 2024
Tags
Health Care
Benzinga
Psychedelics
From
Benzinga
Psilocybin-Assisted Therapy Achieves Positive Clinical Trial Results For Treating Generalized Anxiety
February 28, 2024
Tickers
IXHL
NEWS
Tags
News
Psilocybin/Assisted Therapy
Cannabis
From
Benzinga
FDA Hosts Public Psychedelics Discussion, Discloses Major Growth On Number Of New Psychiatric Drugs Filings Post-2000
January 31, 2024
Tickers
JNJ
MNMD
Tags
Health Care
JNJ
Events
From
Benzinga
Psychedelics Headlines: Anti-inflammatory Effects, Global Drug Survey, 'Synthetic Surprise,' UK's Harm Reduction Hub And More
January 26, 2024
Tickers
AWKNF
CMND
CMPS
FLHLF
Tags
drug reform
OPTHF
Market News
From
Benzinga
Psychedelics Headlines: MDMA & Coping Skills In PTSD, LSD's Perceived Risks, Knowledge Gaps, Surveys & More
January 15, 2024
Tickers
ATAI
CMND
CMPS
CYBN
Tags
Penny Stocks
News
ATAI
From
Benzinga
DEA Acknowledges Psychedelics & Cannabis Research Needs, Seeks Production Increases
November 01, 2023
Tags
Psychedelics Research
Cannabis Research
Government
From
Benzinga
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.